Home » World » COVID-19: Efficacy of Pfizer, BioNTech coronavirus vaccine drops to 84 pc after 6 months
 
SPEED NEWS

COVID-19: Efficacy of Pfizer, BioNTech coronavirus vaccine drops to 84 pc after 6 months

News Agencies | Updated on: 29 July 2021, 9:29 IST

The efficacy of the Pfizer/BioNTech coronavirus vaccine fell from 96% to 84% after six months, a new preprint report by medRxiv showed on Wednesday.

"Efficacy peaked at 96.2 percent during the interval from 7 days to <2 months post-dose 2, and declined gradually to 83.7 percent from 4 months post-dose 2 to the data cut-off, an average decline of ~6 percent every 2 months," the report said.


Ongoing follow-up is needed to understand the persistence of the vaccine effect over time, it added.

According to data that has not been reviewed, the vaccine was initially 91% effective at preventing COVID-19 over the course of six months.

The US health-oriented news outlet Stat suggested that if the vaccine efficacy keeps declining at the rate described in the study, it will end up being less than 50% within 18 months from the date of vaccination and so a third dose would be required.

(ANI)

Also Read: Coronavirus Pandemic: MP woman seeks financial aid after spending Rs 1.5 cr on husband's treatment for post COVID complications

First published: 29 July 2021, 9:29 IST